| Literature DB >> 27690005 |
Anne Mößeler1, Marion Schmicke2, Martin Höltershinken3, Martin Beyerbach4, Josef Kamphues5.
Abstract
Pancreatic exocrine insufficiency (PEI) is a disease of diverse aetiology-e.g., majority of patients suffering from cystic fibrosis (CF) show PEI congenitally. Malnutrition and malabsorption of nutrients impair growth and nutritional status. As reduced fat digestion leads to a deficiency of fat-soluble vitamins the supplementation is standard, but absorption is a critical point in PEI-patients. The pancreatic duct ligated (PL) pig is an established model for PEI in humans and has been proven to be a suitable model to compare different vitamin additives for supplementation. In a former study, PEI caused distinct growth retardation in young piglets, but did not affect growth in older ones. Our study hypothesised that this age-dependent effect is caused by exhausted body reserves of fat-soluble vitamins and, therefore, extra supply reduces growth retardation. PEI was induced by PL at the age of seven (PL-7) or 16 weeks (PL-16). Controls (C) underwent a sham surgery. Some PL-7 pigs (PL-7 + Vit) were fed a special vitamin additive. PEI reduced the mean final body weight (kg) at 26 weeks of age significantly with lower effect in PL-16-pigs (C:117; PL-7:49.5; PL-7 + Vit:77.1; PL-16:96.4). Extra vitamin supply resulted in an increased growth and normalised serum concentration of alpha-tocopherol, underlining the importance of special supplementation in PEI-patients.Entities:
Keywords: alpha-tocopherol; animal model; cystic fibrosis; fat-soluble vitamins; growth; leptin; pancreatic exocrine insufficiency; pigs; retinyl palmitate
Year: 2016 PMID: 27690005 PMCID: PMC5085675 DOI: 10.3390/ijms17101642
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Body weight development of controls and pancreatic duct ligated (PL) pigs during the course of the trial; pancreatic duct ligation was performed in week 7 for PL-7 and PL-7 + Vit (PL 7 pigs receiving oral vitamin additive) or in week 16 (PL-16); OP: surgery; different letters mark significant (p < 0.05) differences for group-wise comparison at the end of the trial.
Body weight (BW), body length, metacarpus perimeter, feed intake, performance data (body weight gain: feed), and further quantification of proportion of total gastrointestinal tract (GIT), digesta (absolute (kg), and relative to body weight (%)); mean ± SD.
| Parameter | Control | PL-7 | PL-7 + Vit | PL-16 |
|---|---|---|---|---|
| Body weight (BW), kg | 117 ± 8.07 a | 46.2 ± 22.4 d | 73.5 ± 11.9 c | 96.4 ± 9.89 b |
| Body length, nose to tail, cm | 143 ± 5.59 a | 115 ± 13.4 c | 131 ± 9.58 b | 138 ± 6.41 a,b |
| Metacarpus perimeter, cm | 17.0 ± 0.66 a | 12.6 ± 1.40 c | 14.4 ± 0.79 b | 16.2 ± 0.80 a |
| Feed intake, g as fed/day * | 3001 ± 489 a | 1483 ± 993 b | 2721 ± 824 a | 3093 ± 687 a |
| Feed intake, g as fed/kg BW * | 25.5 ± 3.91 a | 29.5 ± 10.6 a,b | 37.1 ± 9.36 b | 33.1 ± 5.29 a,b |
| BW Gain: Feed # | 0.498 ± 0.026 a | 0.272 ± 0.062 d | 0.337 ± 0.037 c | 0.389 ± 0.029 b |
| Empty body weight, kg | 108 ± 7.11 a | 40.9 ± 19.0 d | 64.7 ± 10.8 c | 82.5 ± 8.61 b |
| Relative mass of GIT, % of BW | 7.95 ± 0.86 a | 17.3 ± 2.00 c | 16.3 ± 2.36 b,c | 14.4 ± 2.75 b |
| Digesta, kg | 5.30 ± 1.11 a | 4.64 ± 1.98 a | 7.41 ± 1.34 b | 8.42 ± 1.61 b |
| Digesta, % of BW | 4.49 ± 0.78 a | 9.53 ± 1.35 b | 9.76 ± 1.88 b | 8.72 ± 1.34 b |
* Week 25 of life during ad libitum feeding phase; # body weight gain (kg) per kg feed intake; calculated over the entire study period; different superscripts mark significant (p < 0.05) effect of group.
Figure 2Vitamin A (retinol) concentration (µg/L) in serum of controls and PL pigs during the course of the trial; pancreatic duct ligation was performed in week 7 for PL-7 and PL-7 + Vit or in week 16 (PL-16).
Figure 3Vitamin E (tocopherol) concentration (mg/L) in serum of controls and PL pigs during the course of the trial; pancreatic duct ligation was performed in week 7 for PL-7 and PL-7 + Vit or in week 16 (PL-16); different superscripts mark significant (p < 0.05) differences for group-wise comparison at the same time; black horizontal line marks lower reference value.
Figure 4Vitamin A (retinol) concentration (mg/kg dry matter) in liver tissue of controls and PL pigs at the end of the trial; pancreatic duct ligation was performed in week 7 for PL-7 and PL-7 + Vit or in week 16 (PL-16); different superscripts mark significant (p < 0.05) differences for group-wise comparison.
Figure 5Vitamin E (tocopherol) concentration (mg/kg dry matter) in liver tissue of controls and PL pigs at the end of the trial; pancreatic duct ligation was performed in week 7 for PL-7 and PL-7 + Vit or in week 16 (PL-16); different superscripts mark significant (p < 0.05) differences for group-wise comparison.
Chemical composition of the experimental diet.
| Chemical Composition (per kg Dry Matter) | |||
|---|---|---|---|
| Crude ash (g) | 55.4 | Cu (mg) | 17.8 |
| Crude protein (g) | 198 | Zn (mg) | 148 |
| Crude fat (g) | 111 | Se (mg) | 0.449 |
| Starch (g) | 400 | Vitamin A (IU) | 13,362 |
| Ca (g) | 11.6 | Vitamin D (IU) | 1850 |
| P (g) | 6.59 | Vitamin E (mg) | 123 |